ICTO 2026 Welcomes Michael Thompson as Keynote Speaker to Highlight Innovative Ovarian Cancer Biomarker Detection

 📅 October 8–10, 2026 | 📍 Tokyo, Japan | 🌐 Hybrid Event

We are pleased to announce the 9th Edition of the International Conference on Clinical & Translational Oncology (ICTO 2026), hosted by Magnus Group, taking place October 8–10, 2026, in Tokyo, Japan and Online as a Hybrid Event.

🎤 Keynote Speaker Spotlight | ICTO 2026

We are pleased to welcome Michael Thompson from the University of Toronto, Canada, as a Keynote Speaker (Virtual) at the 9th Edition of the International Conference on Clinical & Translational Oncology (ICTO 2026).

🔬 Keynote Presentation:
“Electrochemical multiplexing strategies for point-of-care detection of ovarian cancer biomarkers”

His presentation will explore innovative electrochemical approaches for the point-of-care detection of ovarian cancer biomarkers, highlighting the potential of translational technologies in advancing cancer diagnosis.

📅 October 8–10, 2026
📍 Tokyo, Japan | Hybrid Event

📝 Abstract Submission: https://magnusconferences.com/cancer-oncology/submit-abstract

🎟️ Register Today: https://magnusconferences.com/cancer-oncology/register

🔗 More Information: https://magnusconferences.com/cancer-oncology/

🌐 Join leading researchers, clinicians, scientists, and oncology professionals from around the world at ICTO 2026.

#ICTO2026 #ClinicalOncology #TranslationalOncology #CancerResearch #OvarianCancer #CancerBiomarkers #Oncology #KeynoteSpeaker #MedicalResearch #TokyoJapan